Skip to content

NAMSW

NewAmsterdam Pharma Co. NV

NASDAQ · Healthcare · Biotechnology · NL

$11.00
−8.33%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 11, 2026
EPS estimate
-$0.49
Revenue estimate
$7.5M

Latest reported

Last report date
Aug 5, 2026
EPS actual
-$0.52
EPS estimate
-$0.48
Revenue actual
$3.7M
Revenue estimate
$2.8M

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
3
EPS in line (12Q)
0
Avg surprise (4Q)
+61.2%
Revenue beats (12Q)
5
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 5, 2026-$0.48-$0.52Miss -7.90%$3.7M
May 7, 2026-$0.46-$0.40Beat 12.85%$3.0M
Feb 18, 2026-$0.56$1.09Beat 294.58%$32.0K
Nov 5, 2025-$0.39-$0.61Miss -54.77%$348.0K
Aug 6, 2025-$0.46-$0.18Beat 60.27%$19.1M
May 8, 2025-$0.49-$0.46Beat 6.66%$3.3M
Feb 26, 2025-$0.49-$0.98Miss -102.33%$13.2M
Feb 28, 2024-$0.57$1.8M
Sep 29, 2023-$0.59$2.0M
Mar 31, 2023-$2.37$1.5M
Nov 28, 2022-$2.14$5.5M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026